• glut 1 br Update on the diagnosis of ERS ERS is generally

  2019-05-31

  

  Update on the diagnosis of ERS ERS is generally diagnosed in patients who display ER in the inferior and/or lateral leads presenting with aborted cardiac arrest, documented VF, or polymorphic VT. Consistent with the recent consensus report on ERP [24], ER is recognized if (1) there is an end QRS

• In a recent study Nademanee et al reported

  2019-05-31

  

  In a recent study, Nademanee et al. [76]. reported additional evidence pointing to pathologic changes in the RVOT of patients with BrS that have proved undetectable by echocardiography or MRI. In contrast, imaging techniques in ARVC clearly display morphologic and functional changes (e.g., dilation

• M s adelante del fragmento arriba citado de Mem

  2019-05-30

  

  Más adelante del fragmento arriba citado de Memórias, hallamos otro en el que se aborda la cuestión de la insensibilidad. Graciliano la juzga extraña al igual que extraordinaria le parece la desaparición de los deseos sexuales: afirma que todos los sentidos desfallecían. Si son los sentidos los que

• Interpretation Stakeholders from sectors not historically en

  2019-05-30

  

  Interpretation Stakeholders from sectors not historically engaged in health care are forming unique partnerships with common goals and a willingness to address the challenge of global cancer care. Funding None. Declaration of interests Abstract Background Since 2013 medical students from North

• Introduction Paraneoplastic immune mediated encephalopathy

  2019-05-30

  

  Introduction Paraneoplastic immune-mediated encephalopathy is a newly described disease. In 2005, Vitaliani et al first reported that four young women with ovarian teratoma (OT) had developed acute psychiatric and neurologic symptoms, e.g., seizures, memory deficits, decreased level of consciousnes

• In advanced GIST patients where a course

  2019-05-30

  

  In advanced GIST patients where a course of treatment of Imatinib is interrupted by disease progression, subsequent rechallenge with Imatinib restored tumor control in most patients. In the prospective BFR14 trial, 25 patients with disease progression after interruption of one year of treatment rest

• TAPI-1 br Conflict of interest statement br Acknowledgments

  2019-05-30

  

  Conflict of interest statement Acknowledgments Funded by the Division of Medical Oncology at Princess Margaret Hospital, Toronto, Canada. No pharmaceutical company funding was received. The authors acknowledge the roles of Esther Lee and Tazmin Usmani in trial coordination and Dr. Ranjeeta Mal

• br Update on the diagnosis of ERS

  2019-05-30

  

  Update on the diagnosis of ERS ERS is generally diagnosed in patients who display ER in the inferior and/or lateral leads presenting with aborted cardiac arrest, documented VF, or polymorphic VT. Consistent with the recent consensus report on ERP [24], ER is recognized if (1) there is an end QRS

• Vuelve a aparecer aqu la

  2019-05-30

  

  Vuelve protein kinase aparecer aquí la íntima satisfacción de un Aub cuyas obras, por expeditivas que sean —dos semanas para elaborar toda una exposición— y mediocres que puedan parecer, levantan pasiones entre los entendidos en arte porque en buena medida es a ellos, capaces de mutar la arena en or

• The diagnostic infrastructure in the public

  2019-05-30

  

  The diagnostic infrastructure in the public sector relies mainly on sputum smear microscopy that cannot detect drug resistance. It is only when patients fail to get better on standard treatment, or have recurrence of tuberculosis, that they get screened for MDR-TB, resulting in morbidity, continued

• O processo de sele o

  2019-05-29

  

  O processo de seleção é crucial, pois hydroxypropyl beta cyclodextrin ‘escolhida’ será a responsável, nos próximos cinco anos, pela gestão do hospital determinado, decisão publicada em Diário Oficial. Dois aspectos são merecedores de atenção. Inicialmente, a decisão unilateral de escolha pelo Secret

• br Materials and methods br Results and discussion ABT

  2019-05-29

  

  Materials and methods Results and discussion ABT-737 is a BH3-mimetic targeting Bcl-2, Bcl-XL and Bcl-W. The aim of the experiments was to test whether inhibition of Bcl-2 and Bcl-XL using ABT-737 can eradicate the CD34+/CD38− AML cell population. Bone marrow MNCs from patients (Table 1) were

• Despite impressive progress towards elimination social unres

  2019-05-29

  

  Despite impressive progress towards elimination, social unrest, gaps in the coverage of populations at risk, competing health interests, and possible donor fatigue present challenges to successful elimination of human African trypanosomiasis caused by and subsequent maintenance of this status. The t

• FPET is a valuable tool to support monitoring

  2019-05-29

  

  FPET is a valuable tool to support monitoring of SDG 3·7, which calls for universal access to family planning by 2030, albeit with a focus on demand and utilisation rather than access. Nonetheless, subnational geographic projections must be considered in light of some data limitations. Unmarried wom

• br Discussion Intriguingly in a

  2019-05-29

  

  Discussion Intriguingly, in a case report about elevation of skeletal enzymes in ultramarathon runners, the CK level reached its peak value one day after the run, had a ∼4-day plateau, and began to decline after a few more days. The sustained increase of plasma CK in this athlete was quite differ

15799 records 1009/1054 page Previous Next First page 上5页 10061007100810091010 下5页 Last page